Nektar Therapeutics (NKTR) Receivables - Other (2018 - 2025)
Nektar Therapeutics (NKTR) posted quarterly Receivables - Other of $600000.0 for Q4 2025, down 45.45% year-over-year from $1.1 million in Q4 2024, and down 45.45% quarter-over-quarter from $1.1 million in Q4 2024.
Nektar Therapeutics (NKTR) Receivables - Other (2018 - 2025) Analysis & Trends
Nektar Therapeutics' Receivables - Other history runs 8 years deep, the most recent figure standing at $600000.0 for Q4 2025.
- In Q4 2025, Receivables - Other fell 45.45% year-over-year to $600000.0; the TTM figure through Dec 2025 stood at $600000.0 (down 45.45% YoY), while the FY2025 annual figure was $600000.0, down 45.45% from the prior year.
- Receivables - Other for Q4 2025 stood at $600000.0, down from $1.1 million in the prior quarter.
- The five-year high for Receivables - Other was $1.4 million in Q4 2021, with the low at $500000.0 in Q4 2023.
- The 5-year median for Receivables - Other is $700000.0 (2022), against an average of $860000.0.
- The sharpest annual moves came in 2021 and 2024: Receivables - Other slumped 72.55% in 2021, then surged 120.0% in 2024.
- Nektar Therapeutics' Receivables - Other stood at $1.4 million in 2021, then slumped by 50.0% to $700000.0 in 2022, then retreated by 28.57% to $500000.0 in 2023, then jumped by 120.0% to $1.1 million in 2024, then sank by 45.45% to $600000.0 in 2025.
- Business Quant data shows NKTR's Receivables - Other at $600000.0 in Q4 2025, $1.1 million in Q4 2024, and $500000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Nektar Therapeutics | 1.49 Bn | 919.46 Mn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 1.10 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Dec 31, 2021 | 1.40 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Dec 31, 2020 | 5.10 Mn |
| Dec 31, 2020 | 5.10 Mn |
| Sep 30, 2020 | 5.40 Mn |
| Sep 30, 2020 | 5.40 Mn |
| Jun 30, 2020 | 6.10 Mn |
| Jun 30, 2020 | 6.10 Mn |
| Mar 31, 2020 | 6.20 Mn |
| Mar 31, 2020 | 6.20 Mn |
| Dec 31, 2019 | 6.50 Mn |
| Dec 31, 2019 | 6.50 Mn |